StockData
Lexeo Therapeutics, Inc. logo

Lexeo Therapeutics, Inc. (LXEO) stock

LXEONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$2.95+0.10 (+3.33%)

Close on Nov 18, 2026Market cap $242.04MP/E –Yield –

Lexeo Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Lexeo Therapeutics's total assets was $254.90M at Jun 30, 2026. For fiscal 2025 it was $268.69M, up 82.9% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$268.69M+82.9%
FY2024Dec 31, 2024$146.94M+5.1%
FY2023Dec 31, 2023$139.81M+44.0%
FY2022Dec 31, 2022$97.08M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$254.90M+44.8%
Q1 FY2026Mar 31, 2026$250.36M+99.2%
Q4 FY2025Dec 31, 2025$268.69M+82.9%
Q3 FY2025Sep 30, 2025$143.84M-17.3%
Q2 FY2025Jun 30, 2025$176.07M-8.3%
Q1 FY2025Mar 31, 2025$125.69M-41.0%
Q4 FY2024Dec 31, 2024$146.94M+5.1%
Q3 FY2024Sep 30, 2024$173.87M+217.7%
Q2 FY2024Jun 30, 2024$192.01M+97.8%
Q1 FY2024Mar 31, 2024$213.21M–
Q4 FY2023Dec 31, 2023$139.81M–
Q3 FY2023Sep 30, 2023$54.72M–
Q4 FY2022Dec 31, 2022$97.08M–

More Lexeo Therapeutics figures

See a number that looks wrong?